Amicus Therapeutics

Acquired

Home - Amicus Therapeutics | Advancing Therapies to Treat Rare Diseases

Public · Cranbury, United States · Founded 2002 · $86.0M raised

Employees
501–1000
Founded
2002
Business Model
B2B
Total Funding
$86.0M
Last Round
$55.0M Venture RoundJan 2006
Rounds
4
Type
Public
Acquired by
BioMarin Pharmaceutical Inc.Apr 2026

About

Oral pharmacological chaperone protein therapies to address diseases that result from protein misfolding

Summary

Amicus Therapeutics is a Biotech company based in Cranbury, United States, founded in 2002. It has raised $86.0M in total across 4 rounds, most recently a $55.0M Venture Round round in Jan 2006. Investors include Quaker BioVentures, Canaan Partners and Blackstone.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

AcquisitionDec 2025
$4.8B

Sign up to see all 6 rounds

Seed through Acquisition — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Amicus Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/amicus-therapeutics"><img src="https://indexed.vc/api/badge/company/amicus-therapeutics" alt="Amicus Therapeutics on Indexed.vc" width="260" height="76" /></a>